Impedimed Overview

  • Founded
  • 1999
  • Status
  • Public
  • Employees
  • 69
  • Stock Symbol
  • IPD
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $0.10
  • (As of Friday Closing)

Impedimed General Information


Impedimed Ltd together with its subsidiaries operates in the medical devices space. The company is based in Australia and operates globally, and it generates most of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Medical Supplies
Other Industries
Monitoring Equipment
Stock Exchange
Primary Office
  • Unit 1
  • 50 Parker Court
  • Pinkenba, Queensland 4008
  • Australia
+61 (07) 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Impedimed Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.10 $0.10 $0.02 - $0.14 $127M 1.26B 4.2M

Impedimed Financials Summary

In Thousands,
TTM 30-Sep-2020 FY 2020 30-Jun-2020 FY 2019 30-Jun-2019 FY 2018 30-Jun-2018
EV 35,745 29,761 14,578 76,629
Revenue 3,814 2,930 3,716
EBITDA (13,349) (16,899) (21,336)
Net Income (14,317) (17,248) (21,049)
Total Assets 22,719 15,814 30,682
Total Debt 598 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Impedimed Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Impedimed‘s full profile, request access.

Request a free trial

Impedimed Executive Team (5)

Name Title Board Seat Contact Info
Richard Carreon President, Managing Director & Chief Executive Officer
Phil Auckland Chief Financial Officer & Chief Operating Officer
Morten Vigeland Chief Financial Officer
Chris Bulger Director, Business Development
To view Impedimed’s complete executive team members history, request access »

Impedimed Board Members (2)

Name Representing Role Since
Cherrell Hirst Impedimed Chairman 000 0000
To view Impedimed’s complete board members history, request access »

Impedimed Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Impedimed Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000000 00000 26-Oct-2015 000000000000000000 Surgical Devices 0000000 0000000
XiTRON Technologies 01-Oct-2007 Merger/Acquisition Electronic Equipment and Instruments 0000000 00000
To view Impedimed’s complete acquisitions history, request access »

Impedimed Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 00000000000 01-Oct-2007 000000000000000000 Completed
  • 000000000
To view Impedimed’s complete exits history, request access »